You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 34 No. 10, October 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prostaglandins

A Review of Neurophysiology and Psychiatric Implications

Howard A. Gross, MD; David L. Dunner, MD; Dianne Lafleur; Herbert L. Meltzer, PhD; Helen L. Muhlbauer, MD; Ronald R. Fieve, MD

Arch Gen Psychiatry. 1977;34(10):1189-1196.


Abstract

• This article reviews the function of prostaglandins (PGs) in the nervous system and discusses the possible alterations in PG metabolism as relating to mental illness. The PGs are a unique group of cyclic fatty acids whose immediate precursors are thought to function postsynaptically by inhibition or facilitation of neurotransmission through cyclase inhibition or activation, and by means of a negative feedback loop to inhibit further release of neurotransmitter from the presynaptic nerve. A review of PGs in psychiatric conditions is presented as well as a discussion of the interaction of psychoactive drugs with the PGs. The concluding section of this review discusses possible future strategies to provide insight into PG physiology as it relates to synaptic transmission in normal and pathological conditions in man.



Author Affiliations

From the Department of Internal Medicine, New York Psychiatric Institute (Drs Dunner, Lafleur, Meltzer, and Fieve), and the Section on Experimental Therapeutics, Laboratory of Clinical Sciences, National Institute of Mental Health, Bethesda, Md (Drs Gross and Muhlbauer).


Footnotes

Accepted for publication May 6, 1977.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ibuprofen and Psychotic Exacerbation
KATZ et al.
Am. J. Psychiatry 2002;159:1606-1607.
FULL TEXT  

Diet and behavior in children: methodological considerations
Blouin
Topics in Early Childhood Special Education 1983;3:1-8.
ABSTRACT  

Prostaglandins, Platelets, and Schizophrenia
Rotrosen et al.
Arch Gen Psychiatry 1980;37:1047-1054.
ABSTRACT  

Psychiatric Medicine: An Annotated Bibliography of Recent Literature
CASSEM et al.
ANN INTERN MED 1980;92:444-450.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.